Clinical Trial Update: Comparison of Glucose Values and Variability Between TOUJEO and TRESIBA During Continuous Glucose Monitoring in Type 1 Diabetes Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing glucose values and variability between TOUJEO and TRESIBA during continuous glucose monitoring in adults with type 1 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• TOUJEO (insulin glargine)
• Tresiba (insulin degludec)

Snippet

Sponsor: Sanofi | Conditions: Type 1 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2022-11-14